PART 2 Amendment of the Medical Devices Regulations 2002
4.Amendment of regulation 2 in relation to England, Scotland and Wales (interpretation)
5.Amendment of regulation 16 in relation to England, Scotland and Wales (procedures for general medical devices for clinical investigations)
6.Amendment of regulation 29 in relation to England, Scotland and Wales (procedures for active implantable medical devices for clinical investigations)
8.Amendment of regulation 53 in relation to England, Scotland and Wales (fees in connection with the registration of devices and changes to registration details)
9.Amendment of regulation 53 in relation to Northern Ireland (fees in connection with the registration of devices and changes to registration details)
10.Amendment of regulation 54 in relation to England, Scotland and Wales (fees payable in connection with the designation of approved bodies)
11.Amendment of regulation 55 in relation to England, Scotland and Wales (fees payable in connection with the designation etc. of conformity assessment bodies)
12.Amendment of regulation 55 in relation to Northern Ireland (fees payable in connection with the designation etc. of conformity assessment bodies)
13.Amendment of regulation 56 in relation to England, Scotland and Wales (fees payable in relation to clinical investigation notices)
Part 3 Amendment of the Blood Safety and Quality Regulations 2005
Part 4 Amendment of the Medical Devices (Northern Ireland Protocol) Regulations 2021
18.Amendment of the Medical Devices (Northern Ireland Protocol) Regulations 2021
19.Amendment of regulation 7 (registration of custom-made devices)
21.New regulation 17A (advice in relation to intended clinical investigations)
22.Amendment of regulation 19 (fees payable in connection with the designation of notified bodies)
24.Amendment of Schedule 1 (fees for clinical investigations)
25.Amendment of Schedule 2 (fees in connection with the designation of notified bodies)